Senior bio-tech patent expert joins intellectual property law firm Mathys & Squire as Partner

• Iain Armstrong joins from IP law firm HGF
• Will bring over 20 years of technical and legal expertise

Leading intellectual property law firm Mathys & Squire has appointed Chartered and European Patent Attorney Iain Armstrong as a new Partner in the life sciences team.

Iain joins from intellectual property law firm HGF, and brings over 20 years of biotech IP expertise during which he has worked with some of the world’s most prestigious research organisations and institutions, including AstraZeneca, the University of Oxford, Cancer Research UK and Novartis.

Iain’s particular areas of expertise include:

• Personalised cell-based therapies and therapeutics, notably CAR-T cells & IPSCs
• Wound healing and regenerative medicine
• ADCs

Martin MacLean, Partner and head of the life sciences team at Mathys & Squire says, “I’m absolutely delighted to welcome Iain onboard; it’s a coup for Mathys & Squire to attract a senior attorney of Iain’s calibre. His energy and enthusiasm speak volumes and his track record is exemplary.”

“Iain’s appointment is a major step in furthering Mathys & Squire’s strategic development in the life and medical sciences sectors. His extensive biotech knowledge and legal experience will prove a significant long-term asset to the firm.”

“Iain’s arrival further strengthens our top tier life sciences practice. His expertise will be hugely beneficial to our clients in this ever-advancing sector.”